Mapelli, P.; Ghezzo, S.; Samanes Gajate, A.M.; Preza, E.; Palmisano, A.; Cucchiara, V.; Brembilla, G.; Bezzi, C.; Rigamonti, R.; Magnani, P.;
et al. 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data. Cancers 2022, 14, 334.
https://doi.org/10.3390/cancers14020334
AMA Style
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Palmisano A, Cucchiara V, Brembilla G, Bezzi C, Rigamonti R, Magnani P,
et al. 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data. Cancers. 2022; 14(2):334.
https://doi.org/10.3390/cancers14020334
Chicago/Turabian Style
Mapelli, Paola, Samuele Ghezzo, Ana Maria Samanes Gajate, Erik Preza, Anna Palmisano, Vito Cucchiara, Giorgio Brembilla, Carolina Bezzi, Riccardo Rigamonti, Patrizia Magnani,
and et al. 2022. "68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data" Cancers 14, no. 2: 334.
https://doi.org/10.3390/cancers14020334
APA Style
Mapelli, P., Ghezzo, S., Samanes Gajate, A. M., Preza, E., Palmisano, A., Cucchiara, V., Brembilla, G., Bezzi, C., Rigamonti, R., Magnani, P., Toninelli, E., Bettinardi, V., Suardi, N., Gianolli, L., Scifo, P., Briganti, A., De Cobelli, F., Esposito, A., & Picchio, M.
(2022). 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data. Cancers, 14(2), 334.
https://doi.org/10.3390/cancers14020334
